On Drug Pricing, The President’s Numbers Are Still Off
We checked again. The data has not changed.
The independent source for health policy research, polling, and news.
661 - 680 of 1,303 Results
We checked again. The data has not changed.
Here's a sampling of recent fact checks related to some of the health care claims made during President Donald Trump's Feb. 4 State of the Union speech.
KHN’s Shefali Luthra examines the president’s talking points on a range of topics — from insurance coverage, access to care and affordability issues to preexisting condition protections and prescription drug costs.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
But like all of health care, it’s complicated.
Federal officials unveiled guidance for states that want to opt out of some of the current funding program and instead seek a fixed payment to gain more flexibility.
As the Democratic primary campaign nears pivotal voting, important aspects of health care policy are being overlooked.
The president, who has repeatedly pledged to improve health care and lower prescription drug prices, faces disapproval from a majority of Americans on his policies regarding drug costs, protecting people with preexisting conditions and the Affordable Care Act.
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
California lawmakers are proposing ambitious health care ideas, from creating a state generic drug label to banning the sale of flavored e-cigarette products. Even though Democrats control state government, they’re likely to face pushback from powerful health care industry groups like hospitals.
Democratic presidential candidates also returned to now-familiar themes in debating the differences between "Medicare for All" and more incremental reforms.
Calculations are complicated, but correct.
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
For rural physicians, the burden of responding to the opioid epidemic falls squarely on their already loaded shoulders. For one doctor in a small Wisconsin village, there was no question that she wanted to rise to the challenge.
People with sickle cell disease aren't fueling the opioid crisis, research shows. Yet some ER doctors still treat patients seeking relief for agonizing sickle cell crises as potential addicts.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
© 2026 KFF